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Transcatheter embolization is the mainstay of the therapy of splenic artery aneurysms (SAAs) in patients with portal hypertension.
It is indicated when the SAA diameter reaches 20mm. Although endovascular techniques are effective and safe for the treatment
of medium-sized SAAs, little is known about their applicability to large-sized SAAs. Herein, we report a case of giant SAA, which
was treated with transcatheter coil embolization. The case was not considered suitable for surgery because of the presence of severe
portal hypertension. The procedure was complicated by bacterial infection of the coils within the aneurismatic sac, leading to
the development of hepatic failure. A liver transplant was then successfully performed despite the presence of a nonresponsive
infection.
1. Introduction
Portal hypertension is associated with the development of
splenic artery aneurysms (SAAs) [1–3], where the risk of
spontaneous rupture increases with the aneurysm diameter.
SAAs treatment is indicated when the aneurysm diame-
ter reaches 20mm. Although open surgery has been the
mainstay of therapy, in recent years endovascular techniques
became the first-line therapy. The mean diameter of SAAs
treated with endovascular techniques is usually below 40mm
[4, 5], while the role of these techniques for bulkier SAAs is
less well defined. Herein, we report a case of an unusually
voluminous SAA in a patient with portal hypertension
treated with transcatheter coil embolization.
2. Case Report
In August 2009, a 60-year-old man with cryptogenetic
cirrhosis was referred to our centre. His history revealed
splenomegaly from the age of 16, with secondary throm-
bocytopenia. No clinical signs of decompensation of the
liver disease were present: MELD score was 13 and
Child-Pugh-Turcotte score B7. Physical examination showed
splenomegaly and the presence of a pulsing voluminous
mass, and vascular murmur in the middle and left
upper abdominal quadrants was noted. Platelet count was
26.000/microL (normal values: 150.000–380.000/microL),
and small esophageal varices were documented at endoscopy.
The patient underwent a computed tomography (CT) of the
abdomen which showed liver cirrhosis with signs of portal
hypertension, a tortuous and ectasic splenic artery with some
widely dilated sections (max 24mm caliber), and massive
aneurysmal dilation in themiddle tract (90mmofmaximum
diameter) with partly calcified walls, inducing a cranial dis-
placement of the tail and the body of the pancreas (Figure 1).
Because of the severe portal hypertension, the patient was
not considered eligible for the surgical treatment of SAA. We
therefore decided to proceed with an angiographic approach.
The angiographic study, performed via femoral artery
approach, confirmed a voluminous wide-necked aneurysm
located in the proximal third of the splenic artery, at 40mm
from the ostium, and revealed the presence of a second
smaller SAA communicating with the former. The placement
of a covered stent to straddle the aneurysms failed because
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Figure 1: Computed tomography (CT) of the abdomen showing a tortuous and ectasic splenic artery with some widely dilated sections (max
24mm calibre) and massive aneurysmal dilation in the middle tract (90mm of maximum diameter) with partly calcified walls, inducing a
cranial displacement of the tail and the body of the pancreas.
(a) (b)
Figure 2: The placement of 11 guidewires and 75 coils within the aneurysmal sac.
of the extremely tortuous efferent splenic artery. A different
approach was therefore attempted. The splenic artery blood
flow was controlled by the inflation of a balloon catheter
via occlusion of the proximal artery of the aneurysms to
reduce the risk of aneurysm rupture and migration of the
coils. This allowed the placing of 11 guidewires (“J” Curved
Moveable Core, Boston Scientific, Natick, MA, USA) and
75 coils of different shape, dimensions (diameter range 10–
16mm; length range 120–300mm) and companies (Boston
Scientific, Natick, MA, USA; Cook, Bloomington, IN, USA;
Balt, Montmorency, France) within the aneurysmal sac. The
exclusion of the SAAs with complete preservation of distal
flow to the spleen was thus obtained (Figure 2), as confirmed
by abdominal ultrasound (Figure 3).
A broad-spectrum antibiotic was given intravenously
before, during and after the procedure. The patient was
discharged from the hospital 7 days later in a good clinical
condition.
One month after the embolization, the patient devel-
oped high-moderate grade fever (>38◦C). Although large-
spectrum antibiotic therapy was rapidly started, the fever
worsened and the patient was again hospitalized in our unit.
Abdominal ultrasound and CT scans excluded strokes/spleen
abscesses, while a Tc-99m labelled white cells scintigraphy
showed a progressive accumulation of circular leucocytes
(90 × 90mm) with a sonolucent halo surrounding the
aneurysm wall (Figure 4). A blood culture was positive
for Propionibacterium bacterium acnes, sensitive only to
aminoglycosides, vancomycin, and clindamycin. Diagnosis
of suprainfection of vascular devices was therefore suspected.
Despite adequate antibiotic therapy, the clinical condi-
tions worsened and liver failure developed (MELD 22, Child-
Pugh-Turcotte C11). Because of the low pathogenicity and
virulence of the causative bacteria, and the fact that infection
was confined within the aneurysmatic sac, we decided to
place the patient on the waiting list for a liver transplantation.
The transplantation was performed in March 2010.
During the operation, an en bloc removal of 2/3 of the
distal stomach, spleen, tail and body of the pancreas and
aneurysmatic bags was required because the pancreas and
the transverse colon were tenaciously adherent to aneurysms.
Furthermore, a partial resection of the transverse colon
followed by a laterolateral anastomosis was performed due
to the presence of extensive intestinal injury.
The postoperative period was complicated by the devel-
opment of a pancreatic fistula, which was drained through
the laparotomic wound and in which was resolved gradually
over the following weeks, and by a partial thrombosis of the
superior mesenteric vein, which was resolved through an oral
anticoagulant therapy.
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Figure 3: Abdominal ultrasound confirming the exclusion of the SAAs with complete preservation of distal flow to the spleen.
(a) (b)
Figure 4: Tc-99m labelled white cells scintigraphy showing a progressive accumulation of circular leucocytes (90 × 90mm) with sonolucent
halo surrounding the aneurysm wall.
The patients was discharged 27 days after liver transplan-
tation and, after two years, he is asymptomatic and in good
clinical condition.
3. Discussion
Splenic artery aneurysms are the most common visceral
artery aneurysms, with a reported prevalence of 0.8% at arte-
riography and 0.04–0.10% at autopsy. The prevalence of a
splenic artery aneurysm is substantially increased in patients
with portal hypertension, and it is estimated to be at 7–
20% in patients with cirrhosis [1]. Spontaneous rupture risk
increases with aneurysm diameter, and reasonable preventive
measures are indicated when the aneurysm diameter reaches
20mm [1–5].
Intravascular therapy, including stent implantation and
embolization, is today considered the treatment of choice for
SAAs. Stent implantation the straddling of the aneurysm,
preserving the artery splenic blood flow [4]. Various
embolization techniques exist. may The isolation technique
consists of embolizing both the inflow and the outflow
arteries of the aneurysm. To avoid total splenic infarction,
this strategy may be used only in presence of collateral
arteries, which ensure the splenic flow and cannot be applied
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to aneurysms located at the origin of the splenic artery.
Alternatively, in the packing technique a framework with
interlocking detachable coils is established, and the fibered
coils or microcoils are packed in the aneurysm itself until
there is no blood flow. A balloon catheter is used to control
splenic arterial blood flow during the procedure. Finally,
a combination of the isolation and packing techniques is
used if there are intrasplenic branches that originate from
the aneurysm, in order to prevent recanalization due to
retrograde backflow from the vessels of the splenic side.
The primary technical success rate of transcatheter
embolization is 88%, reaching 100% after a second treatment
[4]. The most frequent complication is the postembolization
syndrome, such as transient fever and pain, resolvable
in little time with symptomatic treatment in most cases
[4, 6]. Less frequent possible complications include transient
elevation of pancreatic enzymes, splenic infarction, infection,
abscess, and, rarely, the rupture of a pseudoaneurysm [1, 6].
Nevertheless, the majority of the data in the literature
concerns the treatment of SAAs of a diameter of less than
40mm, while the optimal treatment of giant SAAs is not
well established. Giant SAAs are a rare entity, and only a few
cases treated with transcatheter embolization are reported in
literature, all with positive result [7–10].
We have described an unusually voluminous SAA occur-
ring in a patient with portal hypertension. The clinical
history, the large size of the aneurysm, and the relatively
preserved liver function led us to the hypothesis that the
underlying liver disease was likely to be a congenital hepatic
fibrosis, and that the aneurysm had developed very slowly
over time. The aneurysm size dictated the need for interven-
tion. In our case, the severe thrombocytopenia and portal
hypertensionmeant that the surgical approach would involve
very high risks, and therefore an angiographic treatment
was chosen. The initially planned placement of a covered
stent failed because of the extremely tortuous efferent splenic
artery. The isolation technique was not considered because
of the absence of adequate collaterals.
We therefore chose the packing technique with the use
of a balloon catheter to control splenic arterial blood flow
during the procedure. We succeeded in eliminating the SAAs
with complete preservation of distal flow to the spleen.
However, the procedure was complicated a few weeks
later by a bacterial contamination of the devices through
Propionibacterium acnes. This complication, uncommon in
the literature data, was probably favoured in our patient
by the high number of coils utilized, which also made the
penetration of effective antibiotics at the outbreak of the
infection extremely difficult. Because the infection could not
be cured by other means, and the subsequent development
of hepatic failure, the only possibility for our patient was
liver transplantation. The adhesions occurring as a result
of an infection of the aneurysmal sac required a visceral
extended resection, but this did not compromise the success
of transplantation.
In conclusion, even though therapeutic comparison
choices appear well-codified today for medium-sized SAAs,
further studies are needed to formulate an algorithm for the
optimal management of giant SAAs, a rare but potentially
life-threatening entity. In the case of transcatheter emboliza-
tion, the risk of a microbial contamination of the numerous
devices utilized, with the subsequent difficult penetration of
antibiotics at the outbreak of the infection, should be taken
in account.
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